Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Learn about the dangers of holding cash. This guide will help you understand the potential risks involved with cash savings.
18,190 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Microsoft marks 40 years since its 1986 IPO, a milestone that underscores the power of long-term investing. The anniv...
Rising tensions with Iran are driving new concerns about sleeper-cell threats on U.S. soil. Defense experts warn of m...
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Nvidia CEO Jensen Huang laid out a striking forecast where AI agents work alongside a much larger human workforce, re...
A quiet road, a moment of confusion, and a spotlight on money. This piece translates a high-profile misstep into acti...
Markets stabilize after brief volatility, but a capital coward mindset keeps risk premia elevated and prices higher a...
Big-cap U.S. stocks are trading at more attractive levels after a year of resilience and rising macro uncertainty. An...
Bitcoin miners start funding AI pivots by borrowing and selling BTC to stay liquid as margins tighten, hash prices fa...
A geopolitical chokepoint isn't just about oil. The Strait of Hormuz also moves a vital portion of global fertilizer....
The moment the invest paperback arrives! in your mailbox signals more than a fresh read. It’s a chance to build a pra...
ServiceNow's stock is down this year, but CEO Bill McDermott argues AI will accelerate growth, not derail it, outlini...